Photocure ASA reported Hexvix®/Cysview® revenues of NOK 115.9 million in the second quarter of 2023, and an EBITDA of NOK 23.4 million.
Photocure ASA reported Hexvix®/Cysview® revenues of NOK 115.9 million in the second quarter of 2023, and an EBITDA of NOK 23.4 million.